Prospective evaluation of plasma Epstein–Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma

BACKGROUND: Plasma Epstein–Barr virus (pEBV) DNA and fluorodeoxyglucose positron emission (PET) reflect tumour burden in advanced NPC. This study hypothesised that a dual endpoint based on assessing pEBV DNA clearance and PET response could predict early drug response. METHODS: Eligible patients und...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Cancer
Main Authors: Ma, Brigette, Hui, Edwin P, King, Ann, Leung, Sing F, Kam, Michael KM, Mo, Frankie, Li, Leung, Wang, Ki, Loong, Herbert, Wong, Ashley, Chan, Charles ML, Chan, KC Allen, Wong, SC Cesar, Lo, YM Dennis, Chan, Anthony TC
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5931094/
https://ncbi.nlm.nih.gov/pubmed/29555989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0026-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki